A bargain. At recent prices, shares of Pfizer have been trading at just 13.7 times the company's 2021 earnings expectations, and that's before factoring in potential coronavirus vaccine sales. ... The company's already on pace to meet this expectation with non-coronavirus revenue expected to rise 6% year over year in 2021.4 Feb 2021
AstraZeneca shares rise as University of Oxford vaccine poised for UK approval
2020-12-29 12:58:00
A new study has indicated that 2mln people a week in the UK would need to be vaccinated to avoid a third wave of the coronavirus outbreak
Copied from Google
I think the smearing of the Oxford Astrazeneca vaccines was all about boosting the Pfizer vaccine share price. Its all about the money.